NB&A Investigates Possible Link Between Actos Diabetes Drug and Bladder Cancer

In June 2011, the FDA announced that taking Actos (pioglitazone) may associated with an increased risk of developing bladder cancer.  The FDA placed the following information on their website:
Additional Information for Patients

  • There may be an increased chance of having bladder cancer when you take pioglitazone.
  • You should not take pioglitazone if you are receiving treatment for bladder cancer.
  • Tell your doctor right away if you have any of the following symptoms of bladder cancer: blood or red color in urine; urgent need to urinate or pain while urinating; pain in back or lower abdomen.
  • Read the Medication Guide you get along with your pioglitazone medicine. It explains the risks associated with the use of pioglitazone.
  • Talk to your healthcare professional if you have questions or concerns about pioglitazone medicines.
  • Report side effects from the use of pioglitazone medicines to the FDA MedWatch program, using the information in the “Contact Us” box at the bottom of the page.

The pharmaceutical lawyers at Neblett, Beard & Arsenault are investigating a possible class action lawsuit over the link between Actos and bladder cancer.  If you have taken Actos for a year or more and developed bladder cancer, we’d like to hear your story.